A group of researchers from the Royal Melbourne Hospital and Peter MacCallum Cancer Centre are investigating a nasal spray option to prevent respiratory viral infections, such as COVID-19 and the flu.
With over 145 participants currently enrolled in the trial, the C-SMART study has been designed specifically for people diagnosed with cancer.
Find out more about C-SMART.
We provide a media service from 6am to 10pm each day. Journalists are welcome to contact our media advisor on-call via the RMH Switchboard on (03) 9342 7000.
During business hours, journalists can email firstname.lastname@example.org. We do not respond to emails outside business hours.